Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus in relapsed/refractory multiple myeloma
NCT00618345Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Mar 2005
- Primary completion
- Oct 2006
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of everolimus in multiple myeloma (MM), plasma cell neoplasm, sponsored by Mayo Clinic. Started Mar 2005; status: completed.
02
Drugs
everolimus
03
Conditions
multiple myeloma (MM)plasma cell neoplasm
Beyond the preview
Go deeper on NCT00618345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00618345.